~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clinical benefits relative to an inclusion criteria-matched natural.
Koios Medical, a fast-growing developer of medical device software, announced it received FDA clearance for Koios DS, an artificial intelligence (AI) based software platform used to diagnose thyroid and breast cancer.